This inventor holds 3 USPTO granted patents. Top assignees: New England Biolabs, Inc., Bank of America, N.a., as Administrative Agent. Active years: 2019-2026.
Company Filing History:
2 out of 345 
1 out of 11 Years Active: 2019-2026
Title: Innovations of Isaac B. Meek in Synthetic RNA Polynucleotides
Introduction
Isaac B. Meek is a notable inventor based in Hopkinton, MA (US). He has made significant contributions to the field of synthetic biology, particularly in the development of methods for creating RNA polynucleotides from DNA oligonucleotides. With a total of 3 patents, his work has implications for various applications in biotechnology.
Latest Patents
Isaac B. Meek's latest patents focus on compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides. These patents describe a process for forming a single RNA polynucleotide from multiple DNA oligonucleotides in a single reaction chamber. The method utilizes combined reagents in a one-step reaction involving DNA polymerase, RNA polymerase, and single-stranded DNA oligonucleotides. Each DNA oligonucleotide contains sequence modules that facilitate the formation of the RNA polynucleotide, excluding the RNA promoter sequence derived from the initial DNA oligonucleotides.
Career Highlights
Isaac B. Meek is currently employed at New England Biolabs, Inc., where he continues to advance his research in synthetic biology. His innovative approaches have positioned him as a key figure in the development of new biotechnological methods.
Collaborations
Throughout his career, Isaac has collaborated with notable colleagues, including G Brett Robb and Dianne S Schwarz. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Isaac B. Meek's work in synthetic RNA polynucleotides showcases his innovative spirit and dedication to advancing biotechnology. His contributions are paving the way for future developments in the field.